KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Prepaid Assets (2018 - 2025)

Twist Bioscience (TWST) has disclosed Prepaid Assets for 8 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 96.99% to $22.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Dec 2025, up 96.99% year-over-year, with the annual reading at $15.2 million for FY2025, 33.42% up from the prior year.
  • Prepaid Assets for Q4 2025 was $22.9 million at Twist Bioscience, up from $15.2 million in the prior quarter.
  • The five-year high for Prepaid Assets was $22.9 million in Q4 2025, with the low at $7.9 million in Q2 2021.
  • Average Prepaid Assets over 5 years is $12.1 million, with a median of $11.8 million recorded in 2022.
  • The sharpest move saw Prepaid Assets soared 102.66% in 2021, then fell 23.16% in 2023.
  • Over 5 years, Prepaid Assets stood at $10.0 million in 2021, then soared by 40.63% to $14.1 million in 2022, then decreased by 8.82% to $12.9 million in 2023, then dropped by 9.49% to $11.6 million in 2024, then skyrocketed by 96.99% to $22.9 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $22.9 million, $15.2 million, and $13.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.